-
New drug application for Aer Jian eye drug abicipar pegol accepted by FDA
Time of Update: 2020-06-08
recently, Allergan and partner Molecular Partners jointly announced that the new drug (http:// application for the treatment of new blood vessels (wet) age-related macular degeneration (nAMD) by
-
Where to treat urinary infections
Time of Update: 2020-05-12
Where is the urinary infection treated? In recent years, the incidence of testicularitis is increasing year by year, the age of onset is also younger, many patients with testicularitis are eager to s
-
Ma Yinglong's "erythromycin ointment" and sunflower pharmaceutical's "Yinqiao cold capsule" are unqualified
Time of Update: 2020-01-19
According to the "notice on drug quality and safety in Beijing in the second half of 2019" issued by the State Food and drug administration, the "erythromycin ointment" (batch number 190126) produced
-
New target immunotoxin! Vicinium initiated rolling submission for the treatment of high-risk BCG unresponsive non muscle invasive bladder cancer (NMIBC
Time of Update: 2019-12-29
December 29, 2019 / Biogen / -- sesen bio is a biopharmaceutical company in the late clinical stage, focusing on the development of targeted fusion protein therapy for cancer Recently, the company ann
-
Will the pharmaceutical industry enter the stagflation channel
Time of Update: 2019-06-06
First of all, the tax burden is heavy after the transition to the two ticket system, the capital flow is becoming slower and slower, and the return period of some enterprises has been more than half a
-
The number of batches issued decreased significantly, and the supervision of vaccine market was upgraded again
Time of Update: 2019-05-03
[market analysis of pharmaceutical stations] vaccines in China are mainly divided into class I and class II vaccines The supply of class I vaccines is subject to unified purchase and marketing, all of
-
[exclusive] in 2019, 23 Chinese pharmaceutical enterprises have been added to anda, and the former overlord Huahai has not achieved anything. The enthusiasm of enterprises to the United States has
Time of Update: 2019-04-22
As of April 18, 2019, 23 application numbers have been added to the Anda approved by the FDA by Chinese pharmaceutical companies, with a year-on-year increase of 53.3% (15 in the same period of 2018)
-
[perspective] domestic heavyweight new drugs launched in May
Time of Update: 2018-06-08
According to the drug intelligence data, in May, the new drugs were approved with 7 acceptance numbers, involving 5 varieties of drugs Here is a brief look at some of the heavier drugs On May 17, the
-
[exclusive] 2017 local medical insurance supplement summary analysis: many provinces and cities have exceeded the scope of national regulations, and ethnic medicine has broad prospects
Time of Update: 2017-12-26
Since the release of the 2017 national new version of the medical insurance catalogue, the local medical insurance supplement catalogue has also come out People from all walks of life in politics and
-
FDA: approval of specific cancer drugs will be accelerated
Time of Update: 2017-12-04
Source: Wuxi apptec Co., Ltd on December 4, 2017, Dr Scott Gottlieb, director of FDA, and Dr Francis Collins, President of NIH, recently held a meeting with the House Energy & Commerce Committee on ho
-
Usage of compound sweetener
Time of Update: 2017-11-04
Introduction: compound sweetener is also a kind of sweetener We don't know this kind of sweetener very well, so how to use it?
-
How to sweeten grapes
Time of Update: 2017-09-08
Through the safety net of Baibai, we can learn the most detailed knowledge of food additives Editor in charge: he xianrob
-
Food additives sodium cyclamate hazards
Time of Update: 2017-09-02
If we don't pay attention to the dosage of sodium cyclamate in use and don't use it according to the national health food law, it will cause great harm to human body What are the hazards of sodium cyclamate as a food additive?
-
Special inspection on the use of Chinese herbal extracts by drug manufacturers in Deyang City
Time of Update: 2016-05-05
Recently, in accordance with the announcement of the State Administration of food and Drug Administration of Deyang on the implementation of the relevant provisions on the supervision and administrati
-
The 1.1 class of anti Alzheimer's candidate drug GIBH130 has been approved by clinical trial
Time of Update: 2016-04-01
Comparison of brain hippocampal slices of disease model mice: oral administration of gibh-130 can protect neurons According to the Chinese Academy of Sciences, gibh-130 and its tablets, a new anti Alz
